Simpson Thacher is representing funds managed by EQT in connection with their syndication to institutional co-investors of over £1 billion of equity interests in Dechra Pharmaceuticals PLC, which is currently subject to a recommended cash acquisition by: (i) funds managed by EQT, and (ii) a wholly owned subsidiary of the Abu Dhabi Investment Authority.
Dechra is a global developer, manufacturer and supplier of products relating to the companion animal, equine, food producing animal and nutrition categories. Founded over 25 years ago and listed on the London Stock Exchange in 2000, today Dechra has operations in 26 countries and nearly 2,500 employees.
EQT is a purpose-driven global investment organization with EUR 224 billion in total assets under management (EUR 126 billion in fee-paying assets under management) within two business segments – Private Capital and Real Assets. EQT owns portfolio companies and assets in Europe, Asia-Pacific and the Americas and supports them in achieving sustainable growth, operational excellence and market leadership.
The Simpson Thacher team includes: Robert Lee, Vandana Harris, Morgan Shubin, Nakul Patel and Anushka Mehta (Private Funds); William Smolinski, Darius Meehan and Preston Irace (Tax).